News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Clinical - Drug Product News
ViaDerma Lead Product TetraStem Shows Promise in Treating Acne 11/21/2014
Sanofi (SAN.PA) Aims To Launch 18 New Drugs By 2020 11/20/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Over-The-Counter Fexofenadine Hydrochloride 60 Mg And Pseudoephedrine Hydrochloride 120 Mg Extended-Release Tablets 11/20/2014
Amneal Pharmaceuticals Launches AG For Novo Nordisk A/S (NVO)’s Activella® 11/20/2014
Endo International plc (ENDP) Announces Launch Of Generic Version Of Valcyte 11/20/2014
IntelliPharmaCeutics Notes Launch Of 5mg Strength Of Focalin XR(R) Generic By Teva Pharmaceutical Industries Limited (TEVA) 11/20/2014
Keryx Biopharmaceuticals (KERX) Announces Trade Name Auryxia for Ferric Citrate 11/19/2014
AstraZeneca PLC (AZN) Shows Off Strong Drug Pipeline As Pfizer (PFE) Deadline Looms 11/18/2014
Teva Canada Announces the Launch of (Pr)Teva-Celecoxib, a generic of (Pr)Celebrex/ 11/18/2014
Peli Biothermal Coolpall Vertos Launch Success In Europe 11/18/2014
Organovo Announces Commercial Release Of The exVive3D™ Human Liver Tissue 11/18/2014
Teva Pharmaceutical Industries Limited (TEVA) Launches Liquid Formulation Of TREANDA® (bendamustine HCI) Injection In U.S. 11/18/2014
Pfizer (PFE) Release: TRUMENBA® (Meningococcal Group B Vaccine) Is Now Available 11/18/2014
Galderma Laboratories Release: The Cetaphil® Brand Revamps RestoraDerm® Product Line 11/17/2014
Mallinckrodt Pharmaceuticals (MNK)'s Generic ADHD Drug Does Not Measure Up To Johnson & Johnson (JNJ)'s Concerta: FDA 11/14/2014
Kremers Urban Pharmaceuticals Inc. Informed By U.S. FDA Of ANDA Reclassification Of Methylphenidate ER 11/14/2014
Mallinckrodt Pharmaceuticals (MNK) Responds To FDA’s Expected Reclassification Of Methylphenidate ER 11/14/2014
Hep C King Gilead Sciences, Inc. (GILD)'s Harvoni Prescriptions Are Breaking Records 11/13/2014
Major Medical Centers Ask Congress To Probe Genentech (RHHBY)'s Distribution Changes 11/13/2014
Novartis AG (NVS) To Deliver Three Million Malaria Treatments For Kids In Zambia 11/13/2014
Afaxys Pharmaceuticals Announces Wider National Availability Of ella® Emergency Contraceptive 11/11/2014
Babies Die While Officials Haggle With Novartis AG (NVS) Over Cost Of Bexsero Vaccine 11/11/2014
Oculus Innovative Sciences, Inc. (OCLS) Commercializes Microcyn®-Based Solution And Hydrogel For Treatment Of Mild-To-Moderate Acne In Europe 11/11/2014
Five Percent Of Medicines In Malaysia Are Counterfeit: Pfizer (PFE) 11/11/2014
Eli Lilly (LLY)'s Trulicity™ (dulaglutide) Now Available In U.S. Pharmacies 11/10/2014
Endo Pharmaceuticals (ENDP) Receives Final Approval For Generic Version Of Valcyte® 11/10/2014
Tetrastem, Lead Product Of ViaDerma, Hopes To Slow Rates Of Diabetic Amputations 11/7/2014
Hospira, Inc. Announces U.S. Launch of Generic Paricalcitol Injection 11/6/2014
ANI Pharmaceuticals, Inc. Announces The Launch Of Methazolamide Tablets USP 11/6/2014
Ranbaxy Laboratories (RANBAXY.BO) Receives Approval From FDA To Market Fenofibrate Capsules USP, 43 mg And 130 mg 11/5/2014
Mylan Inc. (MYL) Launches Generic Loestrin 24 Fe® 11/5/2014
Inergetics, Inc.' OmEssentials® Supplements Line Available At Whole Foods This Fall 11/4/2014
McNeil-PPC, Inc. Release: First FDA-Approved, Once Daily Application 5% Minoxidil Formula For Women Hits The Market 11/4/2014
Pharming Group (PHGUF.PK) And Salix Pharmaceuticals, Ltd. (SLXP) Announce The Launch Of Ruconest® In The U.S. For The Treatment Of Acute Angioedema Attacks In Patients With Hereditary Angioedema (HAE) 11/3/2014
Apricus Biosciences (APRI) Announces The Launch Of Its Novel Topical Treatment For Erectile Dysfunction In Belgium By Sandoz, Inc. 11/3/2014
BioDelivery Sciences International (BDSI) Announces The Availability Of BUNAVAIL™ In The U.S. 11/3/2014
Express Scripts Inc. Says AbbVie (ABBV)'s Drug Could Displace Gilead Sciences, Inc. (GILD)'s Sovaldi On Formulary 10/31/2014
Migranade, Inc. Release: Game Changing Migraine Medication To Be Available November 2014 10/31/2014
When Will Biosimilars Impact The U.S. Market? 10/30/2014
Mylan Inc. (MYL) Launches Generic Viramune XR® 10/30/2014
Omeros Corporation (OMER) Release: Omidria™ Granted Pass-Through Reimbursement Status From CMS 10/30/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Sirolimus Tablets, 1 mg And 2 mg 10/29/2014
Novo Nordisk A/S (NVO) Announces U.S. Launch Of NovoFine® Plus, A New Pen Needle For Patients With Diabetes 10/29/2014
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/28/2014
Octapharma AG Announces Octagam® 10% Now Available For Ordering In U.S. 10/27/2014
Fresenius Kabi AG Launches Kabiven® In The United States 10/27/2014
BioSpace’s Favorite FDA Tricks Or Treats 10/24/2014
European Medicines Agency Completes Review Of Polymyxin-Based Medicines 10/24/2014
Pelvalon Announces New Analysis From The LIFE Pivotal Trial At The 2014 ICS Conference And Unveils The Brand Name For Its Vaginal Bowel Control Therapy 10/24/2014
FDA Release: Gilead Sciences, Inc. (GILD)'s Harvoni® (ledipasvir/sofosbuvir) Approved For The Treatment Of Chronic Hepatitis C, Genotype 1 Infection In Adults; Diplomat To Distribute 10/23/2014
Tekmira (TKMR) Provides Periodic Update On TKM-Ebola Program 10/22/2014
Gilead Sciences, Inc. (GILD)'s $1,000-A-Pill Hepatitis C Drug May Make Financial Sense For Prisons 10/21/2014
Boehringer Ingelheim Pharmaceuticals, Inc. Release: OFEV® (nintedanib) Now Available In The United States 10/21/2014
U.S. Regulators Ask Three Labs For Mapp Biopharmaceutical's ZMapp Ebola Plans 10/20/2014
Government Of Canada Ships NewLink Genetics' Ebola Vaccine To The WHO 10/20/2014
Admedus Cardiocel® To Be Launched In Canada 10/20/2014
Baxter International, Inc. (BAX) Launches HYQVIA In The United States For Adult Patients With Primary Immunodeficiency 10/20/2014
Takeda Pharmaceuticals And Orexigen Therapeutics, Inc. (OREX) Announce Availability Of CONTRAVE® (naltrexone HCI And bupropion HCI) Extended-Release Tablets For Chronic Weight Management In Obese Adults 10/20/2014
Sihuan Pharmaceutical Sends Ebola Drug JK-05 To Africa, Eyes Clinical Trials 10/16/2014
Gilead Sciences, Inc. (GILD) Nervous As Johnson & Johnson (JNJ) Looks To Remain Competitive In Hepatitis C Market 10/16/2014
Breckenridge Pharmaceutical, Inc. Announces Approval of Mefenamic Acid Capsules, USP 250mg 10/14/2014
Chimerix, Inc. (CMRX) Slips As Ebola Patient On Brincidofovir Dies 10/13/2014
Orexo AB (ORXOF) Submits Application To FDA For Expanded Label Of ZUBSOLV® 10/13/2014
Health Canada Release: Safety Information On The Risk Of Blood Clots With Immunoglobulin Products 10/13/2014
PuraMed BioScience Nears Completion Of A Hemp-Derived-Cannabinoid-Based Non-Prescription Medication For Treatment Of Epilepsy Symptoms 10/13/2014
Gilead Sciences, Inc. (GILD)'s Solvadi May Be Barred From UK's Service Plan 10/9/2014
Fujifilm Diosynth Biotechnologies Announces The Launch Of Its ‘Apollo™’ Mammalian Expression Platform 10/9/2014
Purdue Pharma L.P. Commercially Launches Recently Approved 7.5 Mcg/Hour Dosage Strength Of Butrans® (Buprenorphine) Transdermal System CIII 10/9/2014
Boehringer Ingelheim Corporation Release: New COPD Maintenance Treatment Striverdi® Respimat® (olodaterol) Inhalation Spray Now Available in U.S. Pharmacies 10/8/2014
FUJIFILM's Toyama Chemical Avigan Tablet 200mg Administered To Patients Infected With Ebola Virus 10/6/2014
National Institute for Clinical Excellence (NICE) Rejects Another Roche (RHHBY) Leukemia Drug Citing Data Uncertainties 10/6/2014
AstraZeneca PLC (AZN) Release: BRILINTA Preferred Over Clopidogrel In 2014 American Heart Association/American College of Cardiology Guideline For The Management Of Non–ST-Elevation Acute Coronary Syndromes 10/6/2014
Ashland Inc.  (ASH) Announces Global Price Increase For Vinyl Pyrrolidone- And Cellulosic-Based Pharmaceutical Excipient Products 10/6/2014
Medac Pharma, Inc.'s Rasuvo (methotrexate) Injection Now Available For Patients With Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis And Psoriasis 10/6/2014
Mylan Inc. (MYL) Launches Generic Combivir® 10/6/2014
Diploma PLC (DPLM.L) Release: Otezla® (apremilast) Receives Expanded Indication; Diplomat To Distribute 10/2/2014
Prollenium Medical Technologies Release: Lyracaine Topical Anesthetic Now Approved For Sale In Canada 10/1/2014
Ranbaxy Laboratories (RANBAXY.BO) Launches ABSORICA® (isotretinoin) 25 Mg And 35 Mg Capsules In The U.S. Market 10/1/2014
Mapp Biopharmaceutical's Ebola Drug Production Set for Texas, Possibly North Carolina 9/30/2014
Pfizer (PFE) Starts New Viagra Commercials Targeting Women 9/30/2014
Par Pharmaceutical, Inc. Begins Shipment of Generic Exforge® 9/30/2014
LEO Pharma Announced New Taclonex® (Calcipotriene And Betamethasone Dipropionate) Topical Suspension, 0.005%/0.064% Indication For Treatment Of Scalp Plaque Psoriasis In Pediatric Patients Ages 12-17 9/30/2014
Inergetics, Inc. Introduces Surgex® Warrior Sports Nutrition At Winn-Dixie 9/30/2014
Jaguar Animal Health, Inc. Launches First Product, Neonorm™ Calf, At World Dairy Expo 9/29/2014
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Now Available for the 2014/2015 Influenza Season 9/29/2014
Janssen-Cilag International NV (JNJ) Release: CHMP Announces Positive Opinion For REZOLSTA™, A New Once-Daily, Fixed-Dose HIV Therapy Combining Darunavir And Cobicistat 9/29/2014
FUJIFILM's Toyama Chemical Avigan Tablet 200mg Administered To A French Woman Infected With Ebola Virus 9/26/2014
Actavis (ACT) Will Keep Selling Alzheimer's Drug In U.S. For 60 Days 9/26/2014
Sagent Pharmaceuticals, Inc. Announces The Introduction Of Oxaliplatin Injection, USP 9/24/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Levalbuterol Inhalation Solution, USP 9/24/2014
Regeneron Pharmaceuticals, Inc. (REGN) R&D Chief Reveals Allergy Drug May Be Darling Of Its Pipeline 9/23/2014
Anacor Pharmaceuticals, Inc. (ANAC) Announces Commercial Launch Of KERYDIN (tavaborole) Topical Solution, 5% In The United States 9/23/2014
Lannett Company, Inc. (LCI) Launches Oxycodone Hydrochloride Oral Solution 9/22/2014
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved For The European Union 9/22/2014
60 Percent Of New York’s Hep C Patients Will Get Gilead Sciences, Inc. (GILD)'s Sovaldi 9/19/2014
Roche (RHHBY) Introduces A New Fertility Test For Assessment Of Ovarian Reserve For Pregnancy 9/18/2014
Sagent Pharmaceuticals, Inc. Announces The Launch Of Ketorolac Tromethamine Injection, USP 9/18/2014
New Product From Vireo Systems: pH-D Feminine Health Support 9/17/2014
Janssen Pharmaceutical Inc. Release: Prezcobix™ Now Available For Canadians Living With HIV 9/17/2014
Novartis AG (NVS), Roche (RHHBY) Cry Foul On New Swiss Pricing System 9/16/2014
Roche (RHHBY) Battles Counterfeit Rituxin Vials In Germany 9/15/2014
Easton Pharmaceuticals (OP: EAPH) Announces Preparations For North American Product(s) Launch 9/15/2014
Bayer HealthCare (BAY) Announces The Launch Of Aleve® PM: The First And Only OTC PM Pain Reliever With A Sleep Aid Plus The 12-Hour Pain Relieving Strength Of Aleve 9/15/2014
The Medicines Company (MDCO) To Review ORBACTIV™ (Oritavancin) Launch Readiness On Tuesday, September 16, 2014 9/12/2014
Regeneus (RGS.AX) Kvax Cancer Vaccine Available In Australia, U.S. Trial Begins 9/11/2014
EMD Serono Canada Inc. Announces Launch Of The Eeva® Test In Canada 9/11/2014
The Obesity Society Release: New FDA-Approved Weight Loss Drug Adds New Tool For Obesity Treatment 9/11/2014
Cerilliant Corporation Snap-N-Spike® | Snap-N-Shoot® Certified Reference Materials Now Available Through Sigma-Aldrich Corporation (SIAL) 9/10/2014
National Institute for Clinical Excellence (NICE) Rejects Celgene (CELG)'s Abraxane For Pancreatic Cancer Over Limited Benefits, Cost 9/9/2014
Theravance, Inc. (THRX) Provides VIBATIV® (telavancin) Product Update 9/9/2014
Marathon Pharmaceuticals, LLC Launches Zingo® (Lidocaine Hydrochloride Monohydrate) Powder Intradermal Injection System, Topical Local Anesthetic To Manage Venous Access Pain 9/9/2014
Silvergate Pharmaceuticals Release: FDA Approves 2 New Indications For Epaned®, The First And Only Enalapril Powder For Oral Solution 9/8/2014
AstraZeneca PLC (AZN) Release: BYDUREON® Pen, A Treatment Option For Adults With Type 2 Diabetes, Now Available In Pharmacies 9/8/2014
Endo International plc (ENDP) Announces Launch Of Authorized Generic Of FORTESTA® Gel 9/8/2014
Sagent Pharmaceuticals, Inc. Announces The Launch Of Ibandronate Sodium Injection 9/8/2014
Genzyme Corporation (GENZ)'s New Rare Disease Pill Will Cost Patients $310,250 A Year 9/5/2014
UK Watchdog Backs Alexion Pharmaceuticals Inc. (ALXN)'s "Very Expensive" Drug Soliris 9/5/2014
Mylan Inc. (MYL) Launches Generic Boniva® Injection 9/5/2014
National Institute for Clinical Excellence (NICE) Recommends Commissioning Of Eculizumab (Soliris®) For All Patients With aHUS In England 9/4/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Baraclude® Tablets, 0.5mg And 1mg, In The United States 9/4/2014
Iroko Pharmaceuticals Announces Inclusion Of ZORVOLEX® In Key 2015 National Formularies 9/3/2014
Procter & Gamble (PG) Release: Vicks® Breaks Into Allergy And Sinus Category With The Introduction Of Qlearquil™ 9/3/2014
Teva Pharmaceutical Industries Limited (TEVA) Launches SYNCare™ Home Administration Support Program For Patients On SYNRIBO® (Omacetaxine Mepesuccinate) For Injection 9/3/2014
Lundbeck Inc. (LUN.CO) Announces Availability Of NORTHERA™ (droxidopa) Capsules In The U.S. For Symptomatic Neurogenic Orthostatic Hypotension 9/2/2014
Cipla Ltd. Takes A Bite Out Of GlaxoSmithKline (GSK)'s Profits As Copy Of Top Asthma Drug Lauches In Germany, Sweden 9/2/2014
Janssen Research & Development Expands EXPLORER Global Cardiovascular Research Program To Evaluate The Role Of XARELTO® In Addressing Critical Medical Needs 8/29/2014
BioTie Therapies Corp.: Selincro Enters The Market In Germany 8/29/2014
TNI BioTech Announces First Shipment Of Lodonal® To The Republic Of Panama And The Republic Of Malawi 8/27/2014
BBI Solutions Launches A Fully Validated Human Recombinant Cystatin C Antigen 8/27/2014
Eli Lilly and Company (LLY) Release: New Type 2 Diabetes Treatment Jardiance® (empagliflozin) Tablets For Adults Now Available In U.S. Pharmacies 8/26/2014
Ipsen (IPN.PA) Announces Second Resupply Of Increlex® (Mecasermin [Rdna Origin] Injection) In The U.S. In 2014 8/26/2014
Fera Pharmaceuticals Announces Launch of Moxatag® Authorized Generic 8/25/2014
Mylan Inc. (MYL) Launches First Generic Klor-Con® Extended-Release Tablets 8/22/2014
Telomere Biosciences LLC Announces: TELO-20 For Dogs, The World's First Telomere-Lengthening Supplement For Dogs, To Promote Healthy Aging And Longevity 8/21/2014
Pfizer Inc. (PFE) Release: Palbociclib Expanded Access Program Now Open To Eligible U.S. Patients With Hr+, Her2- Advanced Breast Cancer 8/21/2014
Lannett Company, Inc. (LCI) Comments On Utilization Of Digoxin 8/20/2014
Mylan Inc. (MYL) Launches Generic Precedex™ Injection - Another Key Product Approval 8/19/2014
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Will Be Available At Over 230 Passport Health Locations Nationwide 8/19/2014
Fresenius Kabi AG Introduces Acetylcysteine Solution 10% In 4 Ml, 10 Ml And 30 Ml Vials 8/18/2014
Apricus Biosciences (APRI) Announces The Launch Of Its Topical Treatment For Erectile Dysfunction Vitaros® In Germany By Hexal 8/18/2014
Pragma Pharmaceuticals Announces Re-Launch of Moxatag® 8/15/2014
National Institute for Clinical Excellence (NICE) And Johnson & Johnson (JNJ) Urged To End Zytiga Fiasco 8/15/2014
Merck & Co., Inc. (MRK) Statement Regarding Role Of PNEUMOVAX® 23 (Pneumococcal Vaccine Polyvalent) In Updated ACIP Recommendations For Pneumococcal Vaccination In Adults 8/14/2014
PuraMed BioScience Completes the First Production of MigraPure® Gel 8/14/2014
U.S. Panel Says Seniors Should Get Pfizer Inc. (PFE)'s Prevnar 13 8/14/2014
Amneal Pharmaceuticals Announces Four New Generics 8/13/2014
Sanofi (France) (SAN.PA), PATH Roll Out First Large-Scale Batches Of Antimalarial Drug 8/12/2014
Sanofi US (SNY) Launches Authorized Generic Version Of Eloxatin® (oxaliplatin Injection) 8/12/2014
Another Controversial High Price Med: National Institute for Clinical Excellence (NICE) Rejects Roche (RHHBY)'s New $152,850 Breast Cancer Drug 8/11/2014
BTG plc (BTG.L) Release: First Varicose Vein Patient Treated With FDA-Approved Varithena® (polidocanol Injectable Foam) 1% 8/11/2014
Fresenius Kabi AG Release: Diprivan® (Propofol) Injectable Emulsion, USP Now Available In 10 Ml Vials 8/11/2014
Mylan Inc. (MYL) Launches Generic Xeloda® Tablets 8/11/2014
Suneva Medical's Regenica® Skin Care System Gets New Look 8/8/2014
NextSource Biotechnology Gains FDA Approval For Use Of Tradename Gleostine™ (Lomustine), An Anti-Cancer Chemotherapy Agent 8/8/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces The Launch Of ADASUVE® (Inhalation Powder, loxapine) In Guatemala 8/8/2014
A Little Drug From Questcor Pharmaceuticals, Inc. (QCOR) Generates Controversy And A $220 Million Medicare Bill 8/7/2014
Merck & Co., Inc. (MRK) Concerned For Diabetes Patients In Canada As Top Drugs Are Cut From Program 8/6/2014
Troubled GlaxoSmithKline (GSK) Gets A Lift As Express Scripts Inc. Reinstates Lung Drug Advair 8/5/2014
Gilead Sciences, Inc. (GILD) Battles To Shift Debate Over $1,000 Hepatitis Pills From Costs To Cures 8/5/2014
bioCSL Inc. Launches AFLURIA® Shipping Campaign For 2014-2015 Seasonal Influenza 8/5/2014
Cubist Pharmaceuticals, Inc. (CBST)’s Once-Daily SIVEXTRO™ (Tedizolid Phosphate) Available For Physician And Hospital Order In I.V. And Oral Formulations 8/5/2014
Sagent Pharmaceuticals, Inc. Announces The Reintroduction Of Irinotecan Hydrochloride Injection, USP 8/5/2014
Tekmira Pharmaceuticals Corporation (TKMR) Says Ebola Drug Not Used To Treat U.S. Aid Workers 8/4/2014
Blow To Amgen (AMGN)'s Profits As Express Scripts Inc. Drops Drugs From List Of Preferred Drugs 8/4/2014
Chiesi Farmaceutici SpA And uniQure Provide Update On Glybera® Launch 8/4/2014
Certara Corporation Launches D360 In Japan To Improve Drug Discovery And Development Productivity 8/4/2014
Apricus Biosciences (APRI) Announces The Launch Of Its Topical Treatment For Erectile Dysfunction Vitaros® In Sweden By Sandoz, Inc. 8/4/2014
Eli Lilly and Company (LLY) Release: Type 2 Diabetes: Jentadueto® (linagliptin and metformin hydrochloride) Tablets Label Updated To Include New Data On Blood Glucose Reductions In Treatment-Naive Adults With High Baseline A1C 8/4/2014
BioPharm Executive: Have Drugs Finally Been Priced Too High? 7/31/2014
PuraMed BioScience Rebrands Its Natural Migraine Relief Medication, Lipigesic M 7/31/2014
INNOPHARMA Announces Launch Of Olanzapine For Injection, 10mg/Vial In Canada 7/30/2014
GlaxoSmithKline (GSK)'s Tanzeum™ Is Now Available In Pharmacies In The U.S. 7/30/2014
AstraZeneca PLC (AZN) Fights With Pediatrician Group Over Preemie Drug Guidelines 7/29/2014
Akrimax Pharmaceuticals Initiates CONTROL Patient Registry For Tirosint® (Levothyroxine Sodium) Capsules 7/29/2014
The Upsher-Smith Laboratories Galaxy™ Portfolio Of Antiepileptic Drugs Now Available 7/28/2014
Perrigo Company (PRGO) Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 7/28/2014
FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States 7/24/2014
Abbott Introduces New Similac® Breastfeeding Supplement With DHA, Lutein And Vitamin E 7/24/2014
Boehringer Ingelheim Corporation Release: Benefits And Safety Of Pradaxa® (Dabigatran Etexilate Mesylate) Repeatedly Confirmed 7/24/2014
Daiichi Sankyo, Inc. (4568.t) And Eli Lilly and Company (LLY): Heart Patients In England And Wales Offered More Choice Of Therapies As National Institute for Clinical Excellence (NICE) Extends Recommendations For Prasugrel 7/23/2014
Sanofi Pasteur (SASY.PA) Begins Shipping Seasonal Influenza Vaccine For Upcoming 2014-2015 Season In United States 7/22/2014
BioTie Therapies Corp.: Selincro Enters The Market In Spain 7/22/2014
Iroko Pharmaceuticals Continues To Expand Commercialization Of ZORVOLEX Ex-US 7/22/2014
Third Product In Vernalis PLC (VNLPY.PK)’ Cough Cold Pipeline (CCP-08) Achieves Proof-Of-Concept 7/22/2014
Shire Release: Firazyr®: First Subcutaneous Treatment For Acute Attacks Of Rare And Serious Swelling Disorder Now Available In Canada 7/21/2014
Basilea Pharmaceutica (BSLN.SW) To Launch Zevtera®/Mabelio®) (ceftobiprole medocaril) In Europe Through A Commercial Services Provider 7/21/2014
BioAlliance Pharma Announces The Launch Of Sitavig® In The United States By Its Partner Innocutis 7/21/2014
Durata Therapeutics, Inc.  (DRTX) Announces The U.S. Launch Of Dalvance™ 7/18/2014
MediGene AG (MDGEF.PK)'s Drug Veregen® Launched In Canada 7/17/2014
NovaBay Pharmaceuticals, Inc. (NBY) Announces Direct US Marketing-Sales Campaign For New i-Lid™ Cleanser Product 7/16/2014
Bial And moksha8 Announce Exclusive License For The Commercialization Of Eslicarbazepine Acetate (Zebinix® / Exalief®) In Brazil And Mexico 7/15/2014
Celsion Corporation (CLN) Announces Commercialization Of Reagent Products 7/15/2014
EU Nations Join Forces Against Gilead Sciences, Inc. (GILD)'s "Exorbitant" Hepatitis C Drug 7/14/2014
Upsher-Smith Laboratories Announces Immediate Availability Of A Generic Equivalent To Qudexy™ XR (Topiramate) Extended-Release Capsules 7/14/2014
Kaleo Release: EVZIO™ (naloxone HCl injection) Auto-Injector Now Available In The United States For The Emergency Treatment Of Opioid Overdose 7/10/2014
The International Myeloma Foundation Says IMNOVID® (Pomalidomide), The Newest Medication For Advanced Cases Of Multiple Myeloma, Is Approved For Reimbursement In Sweden, Spain, And Switzerland 7/10/2014
NicOx SA (COX.PA) Focuses U S. Operations On National Launches Of Sjo™ And Retnagene™ And Restructures RPS® Licensing Agreement 7/10/2014
BioTie Therapies Corp.: Selincro Receives Positive Draft Guidance From UK's National Institute for Clinical Excellence (NICE) 7/10/2014
PTC Therapeutics, Inc. (PTCT) Announces Expanded Access Program For Translarna™ (ataluren) 7/9/2014
Insight Pharmaceuticals Release: MONISTAT® Announces New Suite Of Complete Care™ Products 7/9/2014



//-->